Lung cancer (LC) is one of the most serious malignant tumors, which has the fastest growing morbidity and mortality worldwide. A role of the lung microbiota in LC pathogenesis has been analyzed, but a comparable role of the gut microbiota has not yet been investigated. In this study, the gut microbiota of 30 LC patients and 30 healthy controls were examined via next-generation sequencing of 16S rRNA and analyzed for diversity and biomarkers. We found that there was no decrease in significant microbial diversity (alpha diversity) in LC patients compared to controls ( P observed = 0.1422), while the composition (beta diversity) differed significantly between patients and controls (phylum [stress = 0.153], class [stress = 0.16], order [stress = 0.146], family [stress = 0.153]). Controls had a higher abundance of the bacterial phylum Actinobacteria and genus Bifidobacterium , while patients with LC showed elevated levels of Enterococcus . These bacteria were found as possible biomarkers for LC. A decline of normal function of the gut microbiome in LC patients was also observed. These results provide the basic guidance for a systematic, multilayered assessment of the role of the gut microbiome in LC, which has a promising potential for early prevention and targeted intervention.
It was first observed that PPL, lipase from porcine pancreas, and several other lipases have a promiscuous ability to catalyse asymmetric aldol reactions between acetones and aldehydes in the presence of water.Biocatalytic promiscuity, a new frontier extending the use of enzymes in organic synthesis, has attracted much attention and expanded rapidly in recent years. 1 It focuses on the enzyme catalytic activities with unnatural substrates and alternative chemical transformations, such as the side ability harbored by decarboxylase to catalyse acyloin condensation. 2 Exploiting enzyme catalytic promiscuity might lead to improvements in existing catalysts and provide novel synthesis pathways that are currently not available. Some elegant works have been done in the last decades. 3 Among the promiscuous enzymes, hydrolases (such as lipase, protease and esterase) undoubtedly play an important role due to their high stability, wide sources and broad range of substrates. 4 Recently, several promiscuous hydrolase-catalysed reactions have been reported. 5 For instance, Wu et al. demonstrated that penicillin G acylase, a hydrolase which is widely used as a biocatalyst in the enzymatic synthesis of b-lactam antibiotics, can catalyse Markovnikov addition of allopurinol to vinyl ester. 6 A further example is reported by the group of Gotor. 7 They found an unprecedented lipase catalysed Michael addition of secondary amines to acrylonitrile. These cases and other relevant reports encouraged us to believe that the catalytic activities for addition reaction rather than the well-known hydrolytic function may also have a natural role in hydrolase evolution.Aldol addition is one of the most useful methods for carboncarbon bond formation in organic synthesis. 8 Berglund and co-workers once used mutant CAL-B (lipase from Candida antarctica) to catalyse aldol addition in 2003. 9 Although the Ser105Ala mutant CAL-B exhibited an increased reaction rate as compared with the wide type in their experiments, both of them showed quite low activities (reaction time more than 50 days). Besides, the enzymatic process is not enantioselective and only simple aliphatic aldehydes, such as propanal and hexanal, had been used. Generally, practical lipase-catalysed aldol reactions hadn't been developed in organic synthesis. To the best of our knowledge, other lipase-catalysed aldol additions, especially asymmetric aldol reactions have never been reported.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.